194 related articles for article (PubMed ID: 3081038)
41. Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identity with activators for the enzymatic hydrolysis of GM1 ganglioside and globotriaosylceramide.
Li SC; Kihara H; Serizawa S; Li YT; Fluharty AL; Mayes JS; Shapiro LJ
J Biol Chem; 1985 Feb; 260(3):1867-71. PubMed ID: 2981875
[TBL] [Abstract][Full Text] [Related]
42. Regional localization of the gene coding for sphingolipid activator protein SAP-1 on human chromosome 10.
Kao FT; Law ML; Hartz J; Jones C; Zhang XL; Dewji N; O'Brien JS; Wenger DA
Somat Cell Mol Genet; 1987 Nov; 13(6):685-8. PubMed ID: 3478817
[TBL] [Abstract][Full Text] [Related]
43. Transport and metabolism of 5'-nucleotidase in a rat hepatoma cell line.
van den Bosch R; Geuze HJ; du Maine AP; Strous GJ
Eur J Biochem; 1986 Oct; 160(1):49-54. PubMed ID: 3021451
[TBL] [Abstract][Full Text] [Related]
44. Sphingolipid activator protein 1 deficiency in metachromatic leucodystrophy with normal arylsulphatase A activity. A clinical, morphological, biochemical, and immunological study.
Schlote W; Harzer K; Christomanou H; Paton BC; Kustermann-Kuhn B; Schmid B; Seeger J; Beudt U; Schuster I; Langenbeck U
Eur J Pediatr; 1991 Jun; 150(8):584-91. PubMed ID: 1683286
[TBL] [Abstract][Full Text] [Related]
45. Incorporation and degradation of GM1 ganglioside and asialoGM1 ganglioside in cultured fibroblasts from normal individuals and patients with beta-galactosidase deficiency.
Kobayashi T; Shinnoh N; Kuroiwa Y
Biochim Biophys Acta; 1986 Jan; 875(1):115-21. PubMed ID: 3079639
[TBL] [Abstract][Full Text] [Related]
46. Sulfatide activator protein. Alternative splicing that generates three mRNAs and a newly found mutation responsible for a clinical disease.
Holtschmidt H; Sandhoff K; Kwon HY; Harzer K; Nakano T; Suzuki K
J Biol Chem; 1991 Apr; 266(12):7556-60. PubMed ID: 2019586
[TBL] [Abstract][Full Text] [Related]
47. Biosynthesis, processing, and intracellular transport of lysosomal acid phosphatase in rat hepatocytes.
Tanaka Y; Harada R; Himeno M; Kato K
J Biochem; 1990 Aug; 108(2):278-86. PubMed ID: 1699935
[TBL] [Abstract][Full Text] [Related]
48. The mechanism for a 33-nucleotide insertion in mRNA causing sphingolipid activator protein (SAP-1)-deficient metachromatic leukodystrophy.
Zhang XL; Rafi MA; DeGala G; Wenger DA
Hum Genet; 1991 Jun; 87(2):211-5. PubMed ID: 2066109
[TBL] [Abstract][Full Text] [Related]
49. A triple-binding-domain model explains the specificity of the interaction of a sphingolipid activator protein (SAP-1) with sulphatide, GM1-ganglioside and globotriaosylceramide.
Wynn CH
Biochem J; 1986 Dec; 240(3):921-4. PubMed ID: 3827882
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and maturation of cross-reactive glycoprotein in fibroblasts deficient in arylsulfatase A activity.
Bach G; Neufeld EF
Biochem Biophys Res Commun; 1983 Apr; 112(1):198-205. PubMed ID: 6132606
[TBL] [Abstract][Full Text] [Related]
51. Synthesis, intracellular processing and secretion of thrombospondin in human endothelial cells.
Vischer P; Beeck H; Voss B
Eur J Biochem; 1985 Dec; 153(3):435-43. PubMed ID: 3935437
[TBL] [Abstract][Full Text] [Related]
52. GM1-ganglioside beta-galactosidase in leukocytes and cultured fibroblasts.
Raghavan SA; Gajewski A; Kolodny EH
Clin Chim Acta; 1977 Nov; 81(1):47-56. PubMed ID: 411612
[TBL] [Abstract][Full Text] [Related]
53. Glycosphingolipid specificity of the human sulfatide activator protein.
Vogel A; Schwarzmann G; Sandhoff K
Eur J Biochem; 1991 Sep; 200(2):591-7. PubMed ID: 1889421
[TBL] [Abstract][Full Text] [Related]
54. Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene.
Schnabel D; Schröder M; Fürst W; Klein A; Hurwitz R; Zenk T; Weber J; Harzer K; Paton BC; Poulos A
J Biol Chem; 1992 Feb; 267(5):3312-5. PubMed ID: 1371116
[TBL] [Abstract][Full Text] [Related]
55. Biosynthesis of the insulin-like growth factor-II (IGF-II)/mannose-6-phosphate receptor in rat C6 glial cells: the role of N-linked glycosylation in binding of IGF-II to the receptor.
Kiess W; Greenstein LA; Lee L; Thomas C; Nissley SP
Mol Endocrinol; 1991 Feb; 5(2):281-91. PubMed ID: 1645456
[TBL] [Abstract][Full Text] [Related]
56. Distribution of saposin proteins (sphingolipid activator proteins) in lysosomal storage and other diseases.
Morimoto S; Yamamoto Y; O'Brien JS; Kishimoto Y
Proc Natl Acad Sci U S A; 1990 May; 87(9):3493-7. PubMed ID: 2110365
[TBL] [Abstract][Full Text] [Related]
57. Molecular form and subcellular distribution of acid beta-galactosidase in fibroblasts from patients with GM1 gangliosidosis, Morquio B disease and galactosialidosis.
Takiyama N; Itoh K; Shimmoto M; Nishimoto J; Inui K; Sakuraba H; Suzuki Y
Brain Dev; 1997 Mar; 19(2):126-30. PubMed ID: 9105659
[TBL] [Abstract][Full Text] [Related]
58. Binding of GM1 ganglioside to a synthetic peptide derived from the lysosomal sphingolipid activator protein saposin B.
Champagne MJ; Lamontagne S; Potier M
FEBS Lett; 1994 Aug; 349(3):439-41. PubMed ID: 8050611
[TBL] [Abstract][Full Text] [Related]
59. Binding of GM1-ganglioside to a synthetic peptide derived from the lysosomal sphingolipid-activator-protein saposin B.
Champagne MJ; Lamontagne S; Potier M
FEBS Lett; 1994 Jun; 347(2-3):265-7. PubMed ID: 8034015
[TBL] [Abstract][Full Text] [Related]
60. Processing of sphingolipid activator proteins and the topology of lysosomal digestion.
Sandhoff K; Kolter T
Acta Biochim Pol; 1998; 45(2):373-84. PubMed ID: 9821868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
